Actualización en carcinoma de pulmón

Contenido principal del artículo

Mercedes Liliana Dalurzo

Resumen

.

Downloads

Download data is not yet available.

Detalles del artículo

Sección

Actualización y avances en investigación

Cómo citar

1.
Dalurzo ML. Actualización en carcinoma de pulmón. Rev Hosp Ital B.Aires [Internet]. 2011 Jun. 10 [cited 2026 Jul. 7];31(2):63-7. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/987

Referencias

Travis WD, Brambilla E, Muller-Herme-link HK, et al. Pathology and genetics. Tu-mours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.

Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75(12):2844-52. DOI: https://doi.org/10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#

Suzuki K, Asamura H, Kusumoto M, et al. “Early” peripheral lung cancer: prognostic sig-nificance of ground glass opacity on thin-sec-tion computed tomographic scan. Ann Thorac Surg. 2002;74(5):1635-9. DOI: https://doi.org/10.1016/S0003-4975(02)03895-X

Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisci-plinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244-85. DOI: https://doi.org/10.1097/JTO.0b013e318206a221

Nicholson AG, Gonzalez D, Shah P, et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mu-cin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol. 2010;5(4):436-41. DOI: https://doi.org/10.1097/JTO.0b013e3181c6ed9b

Noguchi M. Stepwise progression of pul-monary adenocarcinoma--clinical and mo-lecular implications. Cancer Metastasis Rev. 2010;29(1):15-21. DOI: https://doi.org/10.1007/s10555-010-9210-y

Lantuéjoul S, Salameire D, Salon C, et al. Pulmonary preneoplasia-sequential mo-lecular carcinogenetic events. Histopathology. 2009;54(1):43-54. DOI: https://doi.org/10.1111/j.1365-2559.2008.03182.x

Chirieac LR, Dacic S. Targeted Therapies in Lung Cancer. Surg Pathol Clin. 2010;3(1):71-82. DOI: https://doi.org/10.1016/j.path.2010.04.001

Cagle PT, Allen TC, Dacic S, et al. Revo-lution in lung cancer: new challenges for the surgical pathologist. Arch Pathol Lab Med. 2011;135(1):110-6. DOI: https://doi.org/10.5858/2010-0567-RA.1

Sakao Y, Miyamoto H, Sakuraba M, et al. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the im-pact of nonbronchioloalveolar carcinoma com-ponents. Ann Thorac Surg. 2007;83(1):209-14. DOI: https://doi.org/10.1016/j.athoracsur.2006.07.051

Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease re-currence in stage I tumors. Am J Surg Pathol. 2010;34(8):1155-62. DOI: https://doi.org/10.1097/PAS.0b013e3181e4ee32

Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocar-cinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol. 2004;28(2):198-206. DOI: https://doi.org/10.1097/00000478-200402000-00007

Borczuk AC, Qian F, Kazeros A, et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol. 2009;33(3):462-9. DOI: https://doi.org/10.1097/PAS.0b013e318190157c

Yoshizawa A, Motoi N, Riely GJ, et al. Im-pact of proposed IASLC/ATS/ERS classifica-tion of lung adenocarcinoma: prognostic sub-groups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. En prensa